Respiratory syncytial virus infection - risk factors for hospital admission: a case-control study

被引:73
作者
Nielsen, HE [1 ]
Siersma, V
Andersen, S
Gahrn-Hansen, B
Mordhorst, CH
Norgaard-Pedersen, B
Roder, B
Sorensen, TL
Temme, R
Vestergaard, B
机构
[1] Gentofte Univ Hosp, Dept Paediat, DK-2900 Copenhagen, Denmark
[2] Univ Copenhagen, Inst Publ Hlth, DK-1168 Copenhagen, Denmark
[3] Univ Copenhagen, Inst Comp Sci, DK-1168 Copenhagen, Denmark
[4] Statens Serum Inst, Dept Virol, DK-2300 Copenhagen, Denmark
[5] Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen, Denmark
[6] Herlev Univ Hosp, Dept Clin Microbiol, DK-2730 Herlev, Denmark
[7] Odense Univ Hosp, Dept Clin Microbiol, DK-5000 Odense, Denmark
关键词
respiratory syncytial virus; risk factors; hospitalization; antibodies; MBL;
D O I
10.1080/08035250310006304
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Most infants are infected with respiratory syncytial virus (RSV) during the first 2 y of life. The majority have only a mild upper respiratory tract infection, but 1-2% develop a more severe illness and are admitted to hospital. Aim: To carry out a study of risk factors for hospital admission because of RSV infection in Denmark in children aged less than 2 y of age. Methods: The study population included all 1252 children admitted to hospital with verified RSV infection in two Danish counties during the 5-y period 1990-1994. The investigation comprised a retrospective case-control study with five matched controls per case. In a multivariate analysis the risk factors included medical and demographic variables, and in infants <3 mo of age at hospitalization, two aspects of innate immunity: mannose-binding lectin (MBL) concentration and maternal RSV serum antibody titre, measured on eluates from stored dried blood from the infants' 4th day of life. The effect of each risk factor is expressed as an odds ratio, corresponding to the relative risk of being a case rather than a control if the risk factor is present. Results: The following independent risk factors were identified: age, sex, month of birth, gestational age, birthweight, presence of a sibling, up to 5 y older than the case, and maternal smoking during pregnancy. There was a marginal effect of maternal RSV antibody levels, but no effect of neonatal serum MBL concentration or of crowding in the household. Conclusions: Ninety percent of cases and 80% of controls had one or more risk factors. Even though several factors were found to increase the risk for hospitalization for RSV disease, all the effects were small and no single specific factor could be identified to explain the hospitalization of the minority of children with RSV infection.
引用
收藏
页码:1314 / 1321
页数:8
相关论文
共 30 条
[1]  
[Anonymous], TXB PEDIAT INFECT DI
[2]   Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid [J].
Boyce, TG ;
Mellen, BG ;
Mitchel, EF ;
Wright, PF ;
Griffin, MR .
JOURNAL OF PEDIATRICS, 2000, 137 (06) :865-870
[3]   RESPIRATORY SYNCYTIAL VIRUS IN EARLY INFANCY - CIRCULATING ANTIBODY AND SEVERITY OF INFECTION [J].
BRUHN, FW ;
YEAGER, AS .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1977, 131 (02) :145-148
[4]   Risk factors for severe respiratory syncytial virus infection among Alaska Native children [J].
Bulkow, LR ;
Singleton, RJ ;
Karron, RA ;
Harrison, LH .
PEDIATRICS, 2002, 109 (02) :210-216
[5]   Prednisolone treatment of respiratory syncytial virus infection:: A randomized controlled trial of 147 infants [J].
Bülow, SM ;
Nir, M ;
Levin, E ;
Friis, B ;
Thomsen, LL ;
Nielsen, JE ;
Holm, JC ;
Moller, T ;
Bonde-Hansen, ME ;
Nielsen, HE .
PEDIATRICS, 1999, 104 (06) :e77
[6]   Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation:: a prospective study [J].
Carbonell-Estrany, X ;
Quero, J ;
Bustos, G ;
Cotero, A ;
Doménech, E ;
Figueras-Aloy, J ;
Fraga, JM ;
García, LG ;
García-Alix, A ;
Del Río, MG ;
Krauel, X ;
Sastre, JBL ;
Narbona, E ;
Roqués, V ;
Hernández, SS ;
Zapatero, M .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (07) :592-597
[7]   MISSING DATA, IMPUTATION, AND THE BOOTSTRAP [J].
EFRON, B .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1994, 89 (426) :463-475
[8]   RESPIRATORY VIRUS IMMUNIZATION .I. A FIELD TRIAL OF 2 INACTIVATED RESPIRATORY VIRUS VACCINES - AN AQUEOUS TRIVALENT PARAINFLUENZA VIRUS VACCINE AND AN ALUM-PRECIPITATED RESPIRATORY SYNCYTIAL VIRUS VACCINE [J].
FULGINITI, VA ;
ELLER, JJ ;
SIEBER, OF ;
JOYNER, JW ;
MINAMITANI, M ;
MEIKLEJOHN, G .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) :435-+
[9]   Surfactant protein a binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity [J].
Ghildyal, R ;
Hartley, C ;
Varrasso, A ;
Meanger, J ;
Voelker, DR ;
Anders, EM ;
Mills, J .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) :2009-2013
[10]   RISK OF PRIMARY INFECTION AND REINFECTION WITH RESPIRATORY SYNCYTIAL VIRUS [J].
GLEZEN, WP ;
TABER, LH ;
FRANK, AL ;
KASEL, JA .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1986, 140 (06) :543-546